Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-Intensity Focused Ultrasound of the Mediodorsal Thalamus for Treatment-resistant Schizophrenia: Circuit Interrogation and Symptom Assessment

NCT05259306 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT05259306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05259306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-Intensity Focused Ultrasound of the Mediodorsal Thalamus for Treatment-resistant Schizophrenia: Circuit Interrogation and Symptom Assessment
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Suspended
Start date
June 30, 2027
Completion date
June 30, 2029
Enrollment
3 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment-resistant schizophrenia